Literature DB >> 16477485

Current issues in immunomodulatory treatment of multiple sclerosis--a practical approach.

Martin Stangel1, Ralf Gold, Achim Gass, Judith Haas, Stefan Jung, Wolfgang Elias, Uwe K Zettl.   

Abstract

Mesh：

Year:  2006        PMID： 16477485     DOI： 10.1007/s00415-006-1108-9

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  19 in total

1.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Authors:  L D Jacobs; R W Beck; J H Simon; R P Kinkel; C M Brownscheidle; T J Murray; N A Simonian; P J Slasor; A W Sandrock
Journal:  N Engl J Med       Date:  2000-09-28       Impact factor: 91.245

Review 2.  The diagnosis of primary progressive multiple sclerosis.

Authors:  Jerry S Wolinsky
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

3.  Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis.

Authors:  J de Seze; M Chapelotte; S Delalande; D Ferriby; T Stojkovic; P Vermersch
Journal:  Mult Scler       Date:  2004-10       Impact factor: 6.312

4.  The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort.

Authors:  R Boskovic; R Wide; J Wolpin; D J Bauer; G Koren
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

Review 5.  Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.

Authors:  M Sandberg-Wollheim; D Frank; T M Goodwin; B Giesser; M Lopez-Bresnahan; M Stam-Moraga; P Chang; G S Francis
Journal:  Neurology       Date:  2005-08-10       Impact factor: 9.910

6.  A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

Authors:  B G Weinshenker; P C O'Brien; T M Petterson; J H Noseworthy; C F Lucchinetti; D W Dodick; A A Pineda; L N Stevens; M Rodriguez
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 7.  [MRI follow-up in multiple sclerosis. A guideline for quality assurance].

Authors:  A Gass; E W Radü; M Filippi; L Kappos
Journal:  Rofo       Date:  1999-06

8.  Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination.

Authors:  J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

9.  New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes.

Authors:  Catherine M Dalton; Peter A Brex; Katherine A Miszkiel; Kryshani Fernando; David G MacManus; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422
View more
  1 in total

Review 1.  Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.

Authors:  Chaitanya R Joshi; Vinod Labhasetwar; Anuja Ghorpade
Journal:  J Neuroimmune Pharmacol       Date:  2017-02-03       Impact factor: 4.147
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.